Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Ludwig

Showing results (91-100 of 267) with videos related to

Pageof 27
Sort By:
Haematology and Blood Transfusion|January 1, 1990
Cytogenetics of childhood acute lymphoblastic leukemia in multicenter trialsJ Harbott, J Ritterbach, G Janka-Schaub, et al.
Onkologie|June 1, 1990
Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemiaW D Ludwig, J J van Dongen, E Thiel, et al.
Leukemia|January 1, 1994
Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangementC A Schmidt, G Przybylski, D Vogel, et al.
AIDS Research and Human Retroviruses|September 16, 1998
Sequence analysis of the first HTLV-I infection in Germany without relations to endemic areasH Ellerbrok, C Fleischer, M Salemi, et al.
Lancet (London, England)|August 31, 1985
Mitozantrone and high-dose cytarabine in refractory adult acute myeloid leukaemiaW Hiddemann, H Kreutzmann, W D Ludwig, et al.
Annals of Hematology|January 5, 2002
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapyJ Grenzebach, M Schrappe, W D Ludwig, et al.
Leukemia|June 22, 2001
In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activityC Wuchter, D Krappmann, Z Cai, et al.
British Journal of Haematology|August 10, 2000
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemiaC Wuchter, L Karawajew, V Ruppert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2009
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patientsG Maschmeyer, S Neuburger, L Fritz, et al.
Annals of Hematology|October 31, 1998
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemiaR Ratei, C Sperling, L Karawajew, et al.
Pageof 27

Showing results (91-100 of 267) with videos related to

Sort By:
Pageof 27
Haematology and Blood Transfusion|January 1, 1990
Cytogenetics of childhood acute lymphoblastic leukemia in multicenter trialsJ Harbott, J Ritterbach, G Janka-Schaub, et al.
Onkologie|June 1, 1990
Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemiaW D Ludwig, J J van Dongen, E Thiel, et al.
Leukemia|January 1, 1994
Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangementC A Schmidt, G Przybylski, D Vogel, et al.
AIDS Research and Human Retroviruses|September 16, 1998
Sequence analysis of the first HTLV-I infection in Germany without relations to endemic areasH Ellerbrok, C Fleischer, M Salemi, et al.
Lancet (London, England)|August 31, 1985
Mitozantrone and high-dose cytarabine in refractory adult acute myeloid leukaemiaW Hiddemann, H Kreutzmann, W D Ludwig, et al.
Annals of Hematology|January 5, 2002
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapyJ Grenzebach, M Schrappe, W D Ludwig, et al.
Leukemia|June 22, 2001
In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activityC Wuchter, D Krappmann, Z Cai, et al.
British Journal of Haematology|August 10, 2000
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemiaC Wuchter, L Karawajew, V Ruppert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2009
A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patientsG Maschmeyer, S Neuburger, L Fritz, et al.
Annals of Hematology|October 31, 1998
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemiaR Ratei, C Sperling, L Karawajew, et al.
Pageof 27